Table 1 Characteristics of patients who did not have or had early- or late-catheter-related thrombosis.

From: Early prophylaxis of central venous catheter-related thrombosis using 1% chlorhexidine gluconate and chlorhexidine-gel-impregnated dressings: a retrospective cohort study

 

No CRTa

(n = 60)

Early CRTb

(n = 52)

p value*

Late CRTc

(n = 22)

p value*

Skin antiseptic and catheter site dressing combination, n (%)

 CGCD

39 (65)

14 (27)

 < .001

12 (55)

.445

 PITD

21 (35)

38 (73)

10 (45)

Age, years, median,

67

69

.259

71

.946

mean (range)

65 (31–89)

68 (37–92)

62 (26–81)

Sex, n (%)

 Male

35 (58)

33 (63)

.698

18 (82)

.068

 Female

25 (42)

19 (37)

4 (18)

APACHE II score, median,

16

16

.479

15

.156

mean (range)

17 (5–29)

17 (5–38)

15 (7–30)

Admission type, n (%)

 Medical

13 (22)

10 (19)

.817

8 (36)

.253

 Surgical

47 (78)

42 (81)

14 (64)

Infection, n (%)

40 (67)

32 (62)

.693

19 (86)

.100

 CLABSI, n (%)

1 (1.7)

1 (1.9)

1.000

2 (9.1)

.174

Malignancy, n (%)

16 (27)

16 (31)

.678

5 (23)

.783

Prophylactic anticoagulation, n (%)

30 (50)

28 (54)

.708

18 (82)

.012

CVC-exit site, n (%)

 Right

37 (62)

33 (63)

1.000

11 (50)

.449

 Left

23 (38)

19 (37)

11 (50)

CVC type, n (%)

 Type Ad

42 (70)

26 (50)

.035

11 (50)

.120

 Type Be

18 (30)

26 (50)

11 (50)

  1. APACHE II, Acute Physiology and Chronic Health Evaluation II; CGCD, 1% alcoholic chlorhexidine gluconate and chlorhexidine-gel-impregnated dressing; CLABSI, central line-associated bloodstream infections; CRT, catheter-related thrombosis; CVC, central venous catheter; PITD, 10% aqueous povidone-iodine and standard transparent dressing.
  2. *The chi-square test or Fisher’s exact test was used to analyse categorical variables, and the Mann–Whitney U test was used to analyse continuous variables.
  3. aNo catheter-related thrombosis defined as an absence of catheter-related thrombosis during the 14-day period after central venous catheter insertion.
  4. bEarly catheter-related thrombosis defined as catheter-related thrombosis within 7 days after central venous catheter insertion.
  5. cLate catheter-related thrombosis defined as catheter-related thrombosis from day 8 until day 14 after central venous catheter insertion.
  6. dType A was a poly (2-methoxyethylacrylate)-coated central venous catheter.
  7. eType B was a urokinase and heparin-coated central venous catheter.
Back to article page